Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Wall Street
Price Targets
TEVA Price Targets Summary
Teva Pharmaceutical Industries Ltd
According to Wall Street analysts, the average 1-year price target for TEVA is 15.5 USD .
TEVA Last Price Targets
Teva Pharmaceutical Industries Ltd
The latest public price target was made on Feb 12, 2024 by
David Amsellem
from
Piper Sandler
,
who expects
TEVA
stock to
rise by 38%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
David Amsellem
Piper Sandler
|
19
USD
Upside 38% |
2 months ago
Feb 12, 2024
|
Piper Sandler Upgrades Teva Pharma (TEVA) to Overweight
StreetInsider
|
Operating Income
Forecast
Operating Income Estimate
Teva Pharmaceutical Industries Ltd
For the last 8 years the compound annual growth rate for Teva Pharmaceutical Industries Ltd's operating income is -4%. The projected CAGR for the next 3 years is 9%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TEVA's stock price target?
Price Target
15.5
USD
According to Wall Street analysts, the average 1-year price target for TEVA is 15.5 USD .
What is Teva Pharmaceutical Industries Ltd's Revenue forecast?
Projected CAGR
2%
For the last 8 years the compound annual growth rate for Teva Pharmaceutical Industries Ltd's revenue is -3%. The projected CAGR for the next 3 years is 2%.
What is Teva Pharmaceutical Industries Ltd's Operating Income forecast?
Projected CAGR
9%
For the last 8 years the compound annual growth rate for Teva Pharmaceutical Industries Ltd's operating income is -4%. The projected CAGR for the next 3 years is 9%.
You don't have any saved screeners yet
